Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE)

NCT03027245 is registered in ClinicalTrials.gov with Eisai GmbH as lead sponsor.

NCT NCT03027245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03027245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE)
Lead sponsor
Eisai GmbH
Phase
Observational
Overall status
Completed
Start date
October 13, 2016
Completion date
May 31, 2022
Enrollment
353 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic breast cancer